You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Plans are underway to add genomics data from various Danish cohorts to the browser, which will provide greater insight into disease progression.
The firm said it will use the financing for ongoing development of software and learning models.
University spinout PercayAI will analyze genomic and clinical data from WUSTL's McDonnell Genome Institute in search of potential coronavirus drug combinations.
Working with Amazon and Illumina software tools, startup ICBiome has built a platform to help hospitals spot clusters of pathogens early.
The deal between the two Israeli bioinformatics companies gives BATM a minority stake in Geneyx.
The partners plan to build a database of genomic and patient-reported data to identify how genetics can impact disease outcome.
The center, based in Barcelona, Spain, has built a search tool for quickly locating genetic variants and associated metadata for the novel coronavirus.
Covance hopes to improve and accelerate oncology clinical trial matching with the Tempus technology platform and network.
The grant will allow Weill Cornell to study genetic, social, and clinical factors that might explain why COVID-19 disproportionally affects minorities in the US.
Genuity, formerly known as WuXi NextCode, will sequence, analyze, and harmonize samples from Vanderbilt's biobank to inform biomarker and drug discovery.
The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.
According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.